CLINICAL TRIALS PROFILE FOR COMPRO
✉ Email this page to a colleague
All Clinical Trials for COMPRO
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03435003 ↗ | Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy | Unknown status | Stony Brook University | Phase 4 | 2017-08-28 | Bariatric surgery remains the most effective therapy for obesity. Postoperative nausea and vomiting (PONV) are commonly reported following bariatric surgery. The proposed study focuses on the most common bariatric procedure performed, laparoscopic sleeve gastrectomy (LSG), and aims to assess the effect of a post-operative nausea and vomiting-specific intervention. The investigators hypothesize that the intervention group will experience a reduction of nausea-related prolonged hospital stay and significantly improve patient-reported quality of recovery from surgery and quality of life. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for COMPRO
Condition Name
Clinical Trial Locations for COMPRO
Trials by Country
Clinical Trial Progress for COMPRO
Clinical Trial Phase
Clinical Trial Sponsors for COMPRO
Sponsor Name